# Evaluation of Gadoterate in Patients With Renal Dysfunction

> **NCT02382380** · PHASE4 · TERMINATED · sponsor: **Loyola University** · enrollment: 46 (actual)

## Conditions studied

- Renal Dysfunction

## Interventions

- **DRUG:** Gadoterate
- **OTHER:** No Gadoterate

## Key facts

- **NCT ID:** NCT02382380
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11-05
- **Primary completion:** 2024-03-20
- **Final completion:** 2024-03-20
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** The study was terminated by the Institutional Review Board
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02382380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02382380, "Evaluation of Gadoterate in Patients With Renal Dysfunction". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02382380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*